Safety tracking study for Awiqli in diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study monitors how well Awiqli works and any side effects in people with diabetes. It's designed to gather real-world safety information, so you can take Awiqli as your doctor prescribes while contributing to important research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been prescribed Awiqli by your doctor for your diabetes.
- You have any type of diabetes (type 1, type 2, etc.).
- You are any age and either male or female.
- You can understand and agree to take part in the study.
- You haven’t had low blood sugar symptoms or an allergic reaction to Awiqli ingredients.
- You are not currently in another drug study or had an experimental drug in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests an AI system that helps doctors who are not diabetes specialists pick the right medicine to lower your blood sugar. If you have type 2 diabetes and your blood sugar is not well controlled, this could help you get better treatment.
This study tests a medication called dapagliflozin, which is usually for type 2 diabetes, to see if it can be used safely in people with type 1 diabetes. It focuses on preventing a serious side effect called ketoacidosis, where the blood becomes too acidic.
This study tests whether an AI‐powered digital health platform can help people with type 2 diabetes better manage their blood sugar. If you use a smartphone and have had diabetes for at least a year, this may be a convenient way to receive extra support.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.